Editor’s Picks
US Stock Futures Point Higher Amid 15-Year High Treasury Yields
U.S. stock futures indicated a modestly positive start for Wall Street on Thursday morning, signaling a potential rebound after two consecutive sessions of losses, driven...
Stocks React to Federal Reserve Minutes, Inflation Concerns
Stocks faced a turbulent close on Wednesday as market losses deepened following the release of Federal Reserve minutes that underscored lingering inflation concerns. Simultaneously, the...
Inflation Risks Prompt Deliberations at Federal Reserve Meeting
The latest Federal Reserve meeting saw a majority of its members express apprehension regarding potential “significant upside risks” stemming from future inflation pressures. Central to...
TJX Cos Surges as Discount Goods Demand Soars
In a remarkable turn of events, TJX Cos has witnessed a substantial surge in its shares following an upward revision of its fiscal 2024 outlook....
Market Watch: Oil Prices Set to Surge Despite China Concerns
In a promising outlook for the global oil market, UBS strategists have forecasted a rally in oil prices, potentially breaching the $90 per barrel mark...
Nvidia Prepares for Q2 Earnings Report Amid AI Frenzy
Nvidia (NVDA) is poised to unveil its second quarter (Q2) earnings report after the closing bell next Wednesday, marking a pivotal moment that will test...
Weight Loss Drugs Shortages Boost Cardinal Health’s Q4 Profits
In a remarkable turn of events, the surging demand for weight loss drugs has led to shortages and catapulted Cardinal Health (CAH) to a...
Hedge Funds Trim Intel Shares Amidst Tech Surge
In the midst of a robust technology rally during the second quarter, hedge funds have been in a race to capitalize on the soaring market....
DOJ Intensifies Investigation into Tokenization Strategy of Visa
Visa Inc. finds itself under renewed scrutiny from the US Justice Department (DOJ) as the agency intensifies its investigation into the company’s merchant charging practices...
Amazon Pharmacy Disrupts Insulin Pricing with $35 Option
Amazon Pharmacy (AMZN) unveiled a groundbreaking initiative on Tuesday, pledging to provide insulin products at an affordable cost of $35. The move is aimed at...
